Pharmaceutical industry news

GSK Delivers EPS of 104.7p Before Major Restructuring - PharmaLive.com (press release)

GSK Delivers EPS of 104.7p Before Major Restructuring PharmaLive.com (press release), PA - 3 hours ago Our MAGE-3 vaccine, is making good progress and last year we signed an exclusive licensing deal with AFFiRiS to develop two Alzheimera s disease vaccines, ...

StandoutStocks.com: "Stocks that Standout" picks for today are ... - Trading Markets (press release)

StandoutStocks.com: "Stocks that Standout" picks for today are ... Trading Markets (press release), CA - 2 hours ago The human trial was conducted by the HIV Vaccine Trials Network (HVTN), and funded by the National Institute of Allergy and Infectious Disease (NIAID), ...

Raptor Pharmaceuticals Announces Completion of Patient Enrollment ... - FOXBusiness

Raptor Pharmaceuticals Announces Completion of Patient Enrollment ... FOXBusiness - 4 hours ago ... human receptor-associated protein ("RAP") and related proteins that are designed to target cancer, neurodegenerative disorders and infectious diseases. ...

Why GM crops are dangerous - People & the Planet

Why GM crops are dangerous People & the Planet, UK - 2 hours ago If GM foods on the market are causing common diseases or if their effects appear only after long-term exposure, we may not be able to identify the source of ...

Goodness found in real food - Georgia Straight

Goodness found in real food Georgia Straight, Canada - 4 hours ago Proponents of rooibos claim the tea soothes digestive problems and anxiety too. Red Espresso drinks are served at Delaneya s, Beans on Lonsdale, Wicks Cafe, ...

Cytori Patent Allowance Expands Celution System Protection for ... - Centre Daily Times

Cytori Patent Allowance Expands Celution System Protection for ... Centre Daily Times, PA - 5 hours ago The company is dedicated to providing patients with new options for reconstructive surgery, developing treatments for cardiovascular disease, ...

Ivivi Technologies and Grupo Venta Internacional, SA de CV Sign an ... - GlobeNewsWire (press release)

Ivivi Technologies and Grupo Venta Internacional, SA de CV Sign an ... GlobeNewsWire (press release), CA - 4 hours ago ... strategic partners to pursue the cardiac market and others, such as osteoarthritis, neurology and other inflammatory-related conditions if FDA marketing ...

Extavia's Launch Foreshadows Novartis' Future Intentions in the ... - Market Wire (press release)

Extavia's Launch Foreshadows Novartis' Future Intentions in the ... Market Wire (press release) - 4 hours ago "Pharmaceutical Business Review" reported recently that Novartis is likely using Extavia's launch to train and strengthen its neurology sales force in ...

Get a Deep Insight into the US Flavors & Fragrances Market - Earthtimes (press release)

Get a Deep Insight into the US Flavors & Fragrances Market Earthtimes (press release), UK - 3 hours ago ... and aroma of vitamins, minerals, bleaches, antioxidants and other added active ingredients. Through 2012, the cosmetic and toiletry market is expected ...

Raptor Pharmaceuticals Announces Completion of Patient Enrollment ... - FOXBusiness

Raptor Pharmaceuticals Announces Completion of Patient Enrollment ... FOXBusiness - 4 hours ago In the six-month, open-label clinical trial, UC San Diego enrolled a total of 12 adolescent NASH patients receiving a twice daily oral dose of cysteamine ...

Crucell Announces Profits for Full Year 2008 - CNNMoney.com

Crucell Announces Profits for Full Year 2008 CNNMoney.com - 3 hours ago In October 2008, a Phase I clinical trial of the jointly developed TB vaccine was started in Kenya. The study is being conducted by the KEMRI/Walter Reed ...

Aastrom places clinical hold on Phase II heart failure trial - Pharmaceutical Business Review

Aastrom places clinical hold on Phase II heart failure trial Pharmaceutical Business Review - 3 hours ago IMPACT-DCM is the first clinical trial in the US to evaluate the surgical delivery of autologous cells directly into the human heart muscle for the ...

CSC Signs Five-year BPO Services Extension with Aspen Valley Hospital - HealthNEWS. Direct!

CSC Signs Five-year BPO Services Extension with Aspen Valley Hospital HealthNEWS. Direct!, India - 10 minutes ago Aspen Valley Hospital, a 25-bed critical access hospital, provides specialty treatments including allergy/immunology, oncology, pulmonology, neurology, ...

Crucell Announces Profits for Full Year 2008 - CNNMoney.com

Crucell Announces Profits for Full Year 2008 CNNMoney.com - 3 hours ago C6 Technologies: Crucell and its collaborator, the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of ... Crucell to Release Q4 & FY 2008 Results on Thursday, February 5, 2009 CNNMoney.com all 25 news articles

Research and Markets: Examine Pharma Business Management in India ... - Business Wire (press release)

Research and Markets: Examine Pharma Business Management in India ... Business Wire (press release), CA - 5 hours ago The Indian pharmaceutical industry grew at 13% during 2003-07 and the market size is estimated to be US$ 9.77 billion in 2007-08. ...

Ambrilia Biopharma Provides an Update on Reduction of Operations ... - MSNBC

Ambrilia Biopharma Provides an Update on Reduction of Operations ... MSNBC - 1 hour ago Ambrilia's product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, ...

Managing equine respiratory disease - Horse & Hound Online

Managing equine respiratory disease Horse & Hound Online, UK - 2 hours ago This form of respiratory disease is a significant health problem affecting horses, with a prevalence of around 14% in the UK. ...

Mastering Phase IV Clinical Trials

Enhance Your Post-Marketing Trials:

Phase 4 is the fastest-growing area of clinical research today. At an annual growth rate of 23%, industry investment in post-marketing research is expected to top 2 billion in 2007. Rampant growth in Ph...

Additionnal resources regarding this market :

Mastering Phase IV Clinical Trials

Biotech Stocks: Survival of the Fittest - BusinessWeek

Biotech Stocks: Survival of the Fittest BusinessWeek - 1 hour ago For starters, many big pharmaceutical companies are facing the loss of patents on some very profitable drugs. The patents on Pfizer's Lipitor, ...

Post-Launch Brand Marketing in Select Affiliate Markets

Uncover real-world brand budgets from the first three years on the market:

Explore marketing budgets for 8 brands throughout their first, second and third years of market availability. The brands are marketed in the following markets:
<...

Additionnal resources regarding this market :

Post-Launch Brand Marketing in Select Affiliate Markets

Ambrilia Biopharma Provides an Update on Reduction of Operations ... - SYS-CON Media

Ambrilia Biopharma Provides an Update on Reduction of Operations ... SYS-CON Media, NJ - 7 hours ago Ambrilia's product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, ...

PH94 - Patient Education and Direct-to-Patient Communication

Explore benchmark data from 20 patient education programs.

Reach consumers and gain the trust of physicians with direct-to-patient (DTP) communications that feature user-friendly, unbiased patient education content.

...

Additionnal resources regarding this market :

PH94 - Patient Education and Direct-to-Patient Communication

Childrena s medicines a need to be tested more thoroughlya - Belfast Telegraph

ScienceMode

Childrena s medicines a need to be tested more thoroughlya Belfast Telegraph, United Kingdom - 3 hours ago There is an urgent need for more children to take part in clinical trials to make sure medicines can be licensed for safe and effective use on the young, ... Queena s University Belfast study highlights need for licensed ... ScienceMode all 6 news articles

Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch (PH95)

Fund early-stage marketing to realize products' commercial potential:

Some project and brand teams make a critical mistake early in their drugs development lifecycles - they fail to adequately prepare the market for their products. ...

Additionnal resources regarding this market :

Early-Stage Pharmaceutical Marketing Budgets: Preparing for Product Launch (PH95)

Bioheart, Inc. Announces Private Funding Commitments of Up to ... - MSNBC

Bioheart, Inc. Announces Private Funding Commitments of Up to ... MSNBC - 5 hours ago The MARVEL Trial involves 35 US clinical sites and 330 patients, making it one of the largest clinical trials of its kind ever undertaken. ...

PH98 - Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies

Uncover the decisions, investments and timing behind successful relaunch strategies:

Product teams must begin their relaunch planning early to incorporate it into a strong overall lifecycle management strategy. As product teams enter Phase ...

Additionnal resources regarding this market :

PH98 - Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies

Sequenom Restates Clinical Trial Data - Gerson Lehrman Group

Sequenom Restates Clinical Trial Data Gerson Lehrman Group, New York - 58 minutes ago Analysis: Sequenom (NASDAQ:SQNM) restated recent clinical trial data for its molecular diagnostic SEQureDx(tm) test for Down's syndrome. ...

PH96 - Pharmaceutical Customer Relationship Management: Developing and Improving CRM

Uncover CRM strategies, structure, spending and staffing:

As the pharmaceutical industry focuses on maximizing the lifetime value of customers and physicians, customer relationship management plays an increasingly important role. This study...

Additionnal resources regarding this market :

PH96 - Pharmaceutical Customer Relationship Management: Developing and Improving CRM

China-Now leading world pork importers. - Farming UK

China-Now leading world pork importers. Farming UK, UK - 4 hours ago ... the annual low point in demand, USMEF has heard reports of serious respiratory disease outbreaks that could be adding a bearish tone to the market. ...

Uniting RandD and Marketing for Integrated Early-Stage Market Preparation (PH100)

Bridge the structural, cultural, process and communications gaps between R&D and marketing in early-stage drug development: Early-stage product commercialization continues to challenge even the most skilled and highly respected marketing and d...

Additionnal resources regarding this market :

Uniting RandD and Marketing for Integrated Early-Stage Market Preparation (PH100)